$CLRB Cashflow Statement | Understand Stock

$CLRB

$1.21 +$0.00 (0.0%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Loss on disposal of assets
Warrant issuance expense
Change in fair value of warrants
Noncash lease expense
Change in operating lease right-of-use asset
Changes in:
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Lease liability
Cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant & equipment
Cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of underwriting issuance costs
Proceeds from issuance of stock and warrants, net of issuance costs
Proceeds from exercise of warrants and new warrants, net of issuance costs
Proceeds from issuance of common stock, pre-funded warrants and common warrants, net of issuance costs
Cash provided by financing activities

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
CASH AND CASH EQUIVALENTS AT END OF PERIOD
SUPPLEMENTAL DISCLOSURE OF NON-CASH INFORMATION
Conversion of mezzanine equity to permanent equity (Note 6)
Conversion of preferred stock to common stock
Settlement of warrants to equity

Comments